Click here to view all SEDAR® Filings.
TSXEQB
Description | Date | Format |
---|
Prospectus (non pricing) supplement (other than ATM) - English | Jul 25, 2022 | |
Underwriting or agency agreements (or amendment thereto) | Jul 25, 2022 | |
Consent letter of underwriters' legal counsel | Jul 25, 2022 | |
Consent letter of issuer's legal counsel | Jul 25, 2022 | |
Auditor's consent letter | Jul 25, 2022 | |
Draft shelf prospectus supplement - French | Jul 25, 2022 | |
Marketing materials (other than specified derivative) - French | Jul 25, 2022 | |
Marketing materials (other than specified derivative) - French | Jul 25, 2022 | |
Draft shelf prospectus supplement - English | Jul 25, 2022 | |
Marketing materials (other than specified derivative) - English | Jul 25, 2022 | |
Marketing materials (other than specified derivative) - English | Jul 25, 2022 | |
Undertaking to file documents and material contracts | Jul 25, 2022 | |
Non-issuer's submission to jurisdiction and appointment of agent | Jul 25, 2022 | |
Auditors' consent letter | Jul 25, 2022 | |
Undertaking re novel derivatives or asset-backed securities | Jul 25, 2022 | |
Final short form prospectus - French | Jul 25, 2022 | |
Cover letter | Jul 25, 2022 | |
Final short form prospectus - English | Jul 25, 2022 | |
Material change report - French | Jul 25, 2022 | |
Management information circular - French | Jul 25, 2022 | |
Audited annual financial statements - French | Jul 25, 2022 | |
MD&A - French | Jul 25, 2022 | |
Annual information form - French | Jul 25, 2022 | |
Management information circular - French | Jul 25, 2022 | |
MD&A - French | Jul 25, 2022 | |
1-25 26-50 51-75 76-95 |